Meet us at the 10th Congress of the European Academy of Neurology to learn more about our data-driven approach to managing Parkinson’s disease, and how it will help people with Parkinson’s to get the best treatment possible – improving their quality of life!

On Saturday, we had the honor to celebrate the Finnish Movement Disorders Association’s 40th anniversary together with over 200 guests, including people diagnosed with movement disorders and their relatives.

Adamant Health is participating in the 22nd Annual Scandinavian Meeting on Parkinson’s Disease and Related Disorders taking place from 26–27 April 2024 in Helsinki, Finland. Meet us at our booth to learn more about how our technology can help you make more informed treatment decisions for your Parkinson's patients!

Adamant Health is participating in the Deutscher Kongress für Parkinson und Bewegungsstörungen 2024 taking place from 25 to 27 April 2024 in Rostock, Germany. Meet us at our booth to learn more about our data-driven approach for managing Parkinson’s disease!

Movement disorders can be especially difficult to diagnose, treat, and understand. In the next 30 years, there will be a strong increase in the number of people affected by movement disorders and that is why we are promoting #MoveDisorder awareness.

Adamant Health is participating in the International Congress of Parkinson's Disease and Movement Disorders taking place from 27 to 31 August 2023 in Copenhagen, Denmark. Meet us at booth C3-262 to learn more about our data-driven approach!

Adamant Health secures funding from Business Finland's Deep Tech Accelerator program for rapid market entry and targeted growth on international markets. The Deep Tech Accelerator funding will serve as a catalyst in accelerating Adamant Health's entry to selected European markets and drive our growth, particularly within our target customer segments.

We are participating in the Liikehäiriöpäivät 2023, organised by the Finnish Neurological Society and the Finnish Movement Disorder Society, taking place from 4 - 5 May 2023 in Helsinki, Finland. Meet us at our stand or book a meeting to learn more about our technology and service, and how it can help you making better treatment decisions for your patients and improve their quality of life!

The treatment of Parkinson’s disease is currently based on short doctor’s appointments arranged a few times per year, during which patients talk about their symptoms and the doctor makes observations on the patient. As the symptoms may vary from day to day, prescribing medications based on appointments alone is challenging.

Adamant Health Ltd is a health technology company founded in 2020 and it has its roots in medical physics research at the University of Eastern Finland. The company has developed a new measurement and analysis service to support evaluation of movement disorders, such as the symptoms of Parkinson’s disease and myoclonus-epilepsies. Neurocenter Finland has supported the product development.

Hyvä idea vaatii aina hyvän tiimin ja huippuosaamista. Idean lisäksi tarvitaan joku, joka osaa kaupallistaa idean myytävään muotoon. Adamant Health auttaa ratkaisemaan tämän hetken kriittisiä haasteita liittyen terveyteen, ja on juuri siksi yksi alueemme tulevia tähtiä, kiteyttää Business Kuopion yritysneuvoja Marja-Leena Laitinen.

Saara Rissanen was awarded the title of docent in the field of medical physics, especially neurophysiological measurements and motion analysis at the University of Eastern Finland. The award reflects Saara’s long academic career and research work especially in using electromyography (EMG) to measure and analyse movement disorders like Parkinson’s disease.